Jijia Med

Medical Devices & EquipmentSeries ABeijing, Chinajijiamed.com

Latest round

Series A

Last raised

Feb 2026

Total raised

$3.6M

Investors

1

About Jijia Med

, trading under the name Jijia Med, provides respiratory endoscopic equipment for the healthcare sector., Ltd., to form a respiratory interventional diagnosis and treatment management hub. The company works with medical institutions to provide respiratory endoscopic diagnosis and treatment equipment. Its product portfolio includes single-use visual bronchial occlusion catheters (balloon bronchoscopes), bronchoscope placement planning software equipped with AI navigation, electronic endoscope image processors, and ultrasound bronchoscopes.

Who invested in Jijia Med

1 investor across 1 round

See all investors in Jijia Med

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Feb 12, 2026

    Amount

    $3.6M

    Investors

    Locked

Questions about Jijia Med

Who invested in Jijia Med?

Jijia Med has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Jijia Med raised?

Jijia Med has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Jijia Med last raise money?

Jijia Med's most recent round on record is a Series A, in Feb 2026.

What does Jijia Med do?

, trading under the name Jijia Med, provides respiratory endoscopic equipment for the healthcare sector.

Where is Jijia Med headquartered?

Jijia Med is headquartered in Beijing, China.

Which VCs invest in companies like Jijia Med?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Jijia Med's stage. Their profiles are linked below.

Raising like Jijia Med? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.